Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

pierre fabre medicament - milnacipran - fibromialģija

Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

pierre fabre medicament - milnacipran - fibromialģija

Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

centocor b.v. - idebenone - friedreich ataxia - psychoanaleptics, - Ārstēšana friedreich’s ataksija.

Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

biomimetic therapeutics ltd - becaplermin - vadāmā audu reģenerācija, periodonts

Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

les laboratoires servier - agomelatīns - depresijas traucējumi, majors

Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

les laboratoires servier - agomelatīns - depresijas traucējumi, majors

Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - solriamfetol hidrohlorīds - narcolepsy; sleep apnea, obstructive - psychoanaleptics, - sunosi ir norādīts, lai uzlabotu nomodu un samazināt pārmērīgu miegainību dienas laikā pieaugušo pacientu ar narkolepsijas (ar vai bez cataplexy). sunosi ir norādīts, lai uzlabotu nomodu un samazināt pārmērīgu miegainību dienas laikā (eds) pieaugušiem pacientiem ar obstruktīvas miega apnoea (osa), kuru eds nav pienācīgi apstrādāta ar primāro osa terapijas, piemēram, nepārtraukta pozitīva elpceļu spiediena (cpap).

Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - plaušu slimība, hroniska obstruktīva - zāles obstruktīvu elpceļu slimību, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - plaušu slimība, hroniska obstruktīva - zāles obstruktīvu elpceļu slimību, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

merck sharp & dohme b.v. - gefapixant - cough - klepus un auksti preparāti - lyfnua is indicated in adults for the treatment of refractory or unexplained chronic cough.